Works by Porcellati, Francesca
Results: 52
Glucagon as a Therapeutic Approach to Severe Hypoglycemia: After 100 Years, Is It Still the Antidote of Insulin?
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 9, p. 1281, doi. 10.3390/biom11091281
- By:
- Publication type:
- Article
Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus.
- Published in:
- Archives of Physiology & Biochemistry, 2008, v. 114, n. 1, p. 3, doi. 10.1080/13813450801900777
- By:
- Publication type:
- Article
Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128-2136.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Pharmacokinetic and Pharmacodynamic Head-to-Head Comparison of Clinical, Equivalent Doses of Insulin Glargine 300 units · mL<sup>-1</sup> and Insulin Degludec 100 units · mL<sup>-1</sup> in Type 1 Diabetes.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Switching From Insulin Bolus Treatment to GLP-1 RAs Added to Continued Basal Insulin in People With Type 2 Diabetes on Basal-Bolus Insulin.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pharmacokinetics, Pharmacodynamics, and Modulation of Hepatic Glucose Production With Insulin Glargine U300 and Glargine U100 at Steady State With Individualized Clinical Doses in Type 1 Diabetes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
How to Accurately Establish Pharmacokinetics/Pharmacodynamics of Long-Acting Insulins in Humans: Relevance to Biosimilar Insulins.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Pharmacokinetics and Pharmacodynamics of NPH Insulin in Type 1 Diabetes: The Importance of Appropriate Resuspension Before Subcutaneous Injection.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Low Levels of Unmodified Insulin Glargine in Plasma of People With Type 2 Diabetes Requiring High Doses of Basal Insulin.
- Published in:
- Diabetes Care, 2015, v. 38, n. 7, p. e96, doi. 10.2337/dc14-2662
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Insulin Glargine Given in the Evening as Compared With in the Morning in Type 2 Diabetes.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 503, doi. 10.2337/dc14-0649
- By:
- Publication type:
- Article
Thirty Years of Research on the Dawn Phenomenon: Lessons to Optimize Blood Glucose Control in Diabetes.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Metabolism of Insulin Glargine After Repeated Daily Subcutaneous Injections in Subjects With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2012, v. 35, n. 12, p. 2647, doi. 10.2337/dc12-0271
- By:
- Publication type:
- Article
Differential effects of adiposity on pharmacodynamics of basal insulins NPH, glargine, and detemir in type 2 diabetes mellitus.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Care, 2011, v. 34, n. 12, p. 2521, doi. 10.2337/dc11-1064
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of therapeutic doses of basal insulins NPH, glargine, and detemir after 1 week of daily administration at bedtime in type 2 diabetic subjects: a randomized cross-over study.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Pharmacokinetics and Pharmacodynamics of Therapeutic Doses of Basal Insulins NPH, Glargine, and Detemir After 1 Week of Daily Administration at Bedtime in Type 2 Diabetic Subjects.
- Published in:
- Diabetes Care, 2011, v. 34, n. 6, p. 1312, doi. 10.2337/dc10-1911
- By:
- Publication type:
- Article
Pivotal Role of Timely Basal Insulin Replacement After Metformin Failure in Sustaining Long-Term Blood Glucose Control at a Target in Type 2 Diabetes.
- Published in:
- Diabetes Care, 2011, v. 34, p. S220, doi. 10.2337/dc11-s224
- By:
- Publication type:
- Article
Management of Diabetes Mellitus in Acromegaly and Cushing's Disease with Focus on Pasireotide Therapy: A Narrative Review.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2024, v. 17, p. 2761, doi. 10.2147/DMSO.S466328
- By:
- Publication type:
- Article
Short-Term Effects of the Long-Acting Insulin Analog Detemir and Human Insulin on Plasma Levels of Insulin-Like Growth Factor-I and Its Binding Proteins in Humans.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2009, v. 94, n. 8, p. 3017, doi. 10.1210/jc.2008-2838
- By:
- Publication type:
- Article
Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/ mL added to oral antidiabetes agents in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 11, p. 1546, doi. 10.1111/dom.12966
- By:
- Publication type:
- Article
Administration of neutral protamine Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Administration of Neutral Protamine Hagedorn Insulin at Bedtime versus with Dinner in Type 1 Diabetes Mellitus To Avoid Nocturnal Hypoglycemia and Improve Control.
- Published in:
- Annals of Internal Medicine, 2002, v. 136, n. 7, p. 504, doi. 10.7326/0003-4819-136-7-200204020-00007
- By:
- Publication type:
- Article
Mechanisms of Insulin Resistance After Insulin-Induced Hypoglycemia in Humans: The Role of Lipolysis.
- Published in:
- Diabetes, 2010, v. 59, n. 6, p. 1349, doi. 10.2337/db09-0745
- By:
- Publication type:
- Article
Portal Vein Glucose Sensors Do Not Play a Major Role in Modulating Physiological Responses to Insulin-Induced Hypoglycemia in Humans.
- Published in:
- Diabetes, 2009, v. 58, n. 1, p. 194, doi. 10.2337/db08-0641
- By:
- Publication type:
- Article
Physical activity and insulin sensitivity: the RISC study.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Physical Activity and Insulin Sensitivity.
- Published in:
- Diabetes, 2008, v. 57, n. 10, p. 2613, doi. 10.2337/db07-1605
- By:
- Publication type:
- Article
Effect of Oral Amino Acids on Counterregulatory Responses and Cognitive Function During Insulin-Induced Hypoglycemia in Nondiabetic and Type 1 Diabetic People.
- Published in:
- Diabetes, 2008, v. 57, n. 7, p. 1905, doi. 10.2337/db08-0276
- By:
- Publication type:
- Article
Different Brain Responses to Hypoglycemia Induced by Equipotent Doses of the Long-Acting Insulin Analog Detemir and Human Regular Insulin in Humans.
- Published in:
- Diabetes, 2008, v. 57, n. 3, p. 746, doi. 10.2337/db07-1433
- By:
- Publication type:
- Article
Brain Responses to Intravenous, Equipotent Doses of the Long-Acting Acylated Insulin Detemir and Human Regular Insulin in Humans.
- Published in:
- Diabetes, 2007, v. 56, p. A583
- By:
- Publication type:
- Article
Head-to-Head Comparison of the Long-Acting Insulin Analogs Glargine and Detemir: Effects on Glucose and Lipid Metabolism in T1DM.
- Published in:
- Diabetes, 2007, v. 56, p. A52
- By:
- Publication type:
- Article
Counterregulatory hormone and symptom responses to insulin-induced hypoglycemia in the postprandial state in humans.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic autonomic neuropathy.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Renal function markers and insulin sensitivity after 3 years in a healthy cohort, the EGIR-RISC study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 3969, doi. 10.3390/ijms25073969
- By:
- Publication type:
- Article
Insulin therapy and hypoglycaemia: the size of the problem.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2004, v. 20, n. S2, p. S32, doi. 10.1002/dmrr.514
- By:
- Publication type:
- Article
Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 Diabetes.
- Published in:
- Diabetes Care, 2008, v. 31, p. S113, doi. 10.2337/dc08-s227
- By:
- Publication type:
- Article
Comparison of Pharmacokinetics and Dynamics of the Long-Acting Insulin Analogs Glargine and Detemir at Steady State in Type 1 Diabetes.
- Published in:
- Diabetes Care, 2007, v. 30, n. 10, p. 2447, doi. 10.2337/dc07-0002
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of the Long-Acting Insulin Analog Glargine After 1 Week of Use Compared With Its First Administration in Subjects With Type 1 Diabetes.
- Published in:
- Diabetes Care, 2007, v. 30, n. 5, p. 1261, doi. 10.2337/dc06-2208
- By:
- Publication type:
- Article
Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Heart Failure with Preserved Ejection Fraction and Obstructive Sleep Apnea: A Novel Paradigm for Additional Cardiovascular Benefit of SGLT2 Inhibitors in Subjects With or Without Type 2 Diabetes.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Possible Preventative/Rehabilitative Role of Gliflozins in OSA and T2DM. A Systematic Literature Review-Based Hypothesis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Protective Effects of Home T2DM Treatment with Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-transporter-2 Inhibitors Against Intensive Care Unit Admission and Mortality in the Acute Phase of the COVID-19 Pandemic: A Retrospective Observational Study in Italy
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 12, p. 2127, doi. 10.1007/s13300-023-01472-8
- By:
- Publication type:
- Article
Comparative Effectiveness of Switching From First-Generation Basal Insulin to Glargine 300 U/ml or Degludec 100 U/ml in Type 1 Diabetes: The RESTORE-1 Study.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 2, p. 509, doi. 10.1007/s13300-020-00982-z
- By:
- Publication type:
- Article
ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 9, p. 1909, doi. 10.1007/s13300-020-00898-8
- By:
- Publication type:
- Article
Prevention and Management of Severe Hypoglycemia and Hypoglycemia Unawareness: Incorporating Sensor Technology.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Diurnal Cycling of Insulin Sensitivity in Type 2 Diabetes: Evidence for Deviation From Physiology at an Early Stage.
- Published in:
- Diabetes, 2023, v. 72, n. 10, p. 1364, doi. 10.2337/db22-0721
- By:
- Publication type:
- Article
895-P: Improved Glycemic Control with Insulin Glargine 300 U/mL vs. Glargine 100 U/mL in Type 1 Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-895-P
- By:
- Publication type:
- Article